At Antibody Analytics we believe that scientists deserve the best data, and patients deserve the best drugs. Led by a group of talented and engaged scientists, we look at biological problems in an openminded way to deliver beautifully designed, developed and qualified bioassays. We have developed a comprehensive portfolio of assays and platforms that can be tailored to support even the most complex of drug pipelines. Whether designing and developing bespoke bioassays or offering routine analysis on our already established assay platforms, Antibody Analytics has an exceptional track record of delivering beautiful results.

We are primary cell experts and offer a range of off-the-shelf in vitro models or undertake custom projects, to meet your needs. Our key areas of expertise are tailored to the interrogation of binding and function of antibodies, mAbs, bi- and multi-specifics, immune cell engagers, small molecules, immune cell modulators, antibody drug conjugates (ADCs), cell therapies and biosimilars. With expertise that we apply from target validation throughout lead identification, selection, characterisation and pre-clinical services. This includes cell line development capabilities to generate unique tools (target and reporter cells) for custom assay development, unique to your target and modality.